Free Daily Podcast Summary
Power to the Patients: Daily Summaries Delivered
by Brandon Li
Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials. We explore the bottlenecks in today's systems, challenge the status quo and talk about future opportunities for innovation.Looking for a clinical trial? Visit us at www.withpower.com
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- Today29 min
Why Neuroscience Trials Keep Failing and What Could Fix Them
Neuroscience trials often enroll hundreds of patients, run for years, and still end without a clear answer. Some researchers now think a small study with the right measures can tell you more than a large one. In this episode of Power to the Patients, Brandon Li brings together Craig Erickson, Chief Medical Advisor at Spinogenix, and Gabriel Vargas, Chief Medical Officer at CuraSen Therapeutics, to look at why these drugs are so hard to develop and what could work better. They cover what anti-amyloid antibodies do and do not deliver in Alzheimer’s, why synapses sit at the center of so many brain disorders, and what patients and investors should watch next.
- Sep 9, 202641 min
Why Enveda Teaches AI to Read Nature's Chemistry
Isn’t it crazy to think that half of FDA-approved small molecule drugs have roots in nature? But José Trevejo, Chief Medical Officer at Enveda, says the opportunity now is not to romanticize that history, but to make it usable at modern speed. In this episode of Power to the Patients, Brandon Li speaks with José about AI-assisted drug discovery, mass spectrometry, ENV-294 and why the real bottleneck in biotech may no longer be finding molecules. It may be scaling the trials to test them. By combining ancient healing stories with high-throughput technology, researchers now identify these candidates in hours rather than years. This clinical acceleration is rewriting the early-stage discovery playbook.
- Aug 19, 202637 min
Reversing Chemo failure in ovarian cancer with Thomas Zindrick
Platinum chemotherapy is the backbone of ovarian cancer treatment. But for far too many patients, it eventually stops working. In this episode of Power to the Patients, Brandon Li sits down with Thomas Zindrick, CEO and President of Genelux Corporation, to discuss Olvi-Vec, platinum resensitization, and why oncolytic virus therapy could give clinicians a new way to work with existing cancer treatments. Platinum resistance is one of the hardest questions to solve in clinical oncology, but some answers are beginning to emerge.
- Jul 23, 202636 min
The Gout Narrative Keeping Patients Sick and What Crystalys Therapeutics Is Doing Differently
Most people still think gout is a lifestyle condition caused primarily by diet. But this belief is a big reason patients have been underserved for decades. In this episode of Power to the Patients, Brandon Li sits down with James Mackay, CEO and co-founder of Crystalys Therapeutics, to explore what gout patients really need. They unpack what went wrong with Zurampic, why Dotinurad’s profile gives Crystalys Therapeutics a reason to come back to gout and how better trial design could finally move the field beyond old assumptions. For decades, gout has often been framed as a disease caused by lifestyle choices. This episode reframes the conversation entirely.
- Jul 7, 202633 min
Developing a treatment for Alzheimer's in the world of AI with Sacha Schermerhorn
Learn about clinical trial design for small molecule therapies using biomarkers in Alzheimer's research and AI in drug development. Brandon Li talks with Sacha Schermerhorn, Founder and CEO of Babylon Biosciences. They discuss why the industry needs to rethink disease pathology, how to recruit elite talent out of retirement, and the role of fine-tuned AI models in predicting clinical outcomes for patients.
- May 13, 202633 min
How Neuroplasticity Is Shaping the Next Generation of Psychiatric Medicines
Dr. Aaron Koenig, Chief Medical Officer at Delix Therapeutics, sheds light on a new class of medicines designed to promote neuroplasticity without the hallucinogenic effects associated with psychedelics. On this episode of Power to the Patients, Koenig explains to host Brandon Li how neuroplasticogens could provide scalable treatments for depression and other serious brain disorders, why separating plasticity from psychedelic experiences matters for clinical development, and how emerging biomarkers such as qEEG may help measure brain changes in patients. The conversation spans scientific rationale, clinical challenges, and long term potential of plasticity-based therapeutics in psychiatry and neurology.
- Apr 30, 202635 min
70% Remission for Postpartum Depression? The Psychedelic Breakthrough
Postpartum depression treatment advances with psychedelic therapy. Greg Mayes of Reunion Neuroscience discusses luvesilocin drug development. This episode explores how shorter-acting psilocybin analogs offer new hope for mothers. Greg highlights the success of the RECONNECT study and the path to FDA breakthrough designation.
- Apr 15, 202629 min
Why Psychiatry Is Finally Breaking Free From Dopamine
In this episode of Power to the Patients, host Brandon Li sits down with Ken Kramer, PhD, Vice President and Head of Neuropsychiatry Medical Affairs at Bristol Myers Squibb, to explore why psychiatry has lagged behind other therapeutic areas and what’s finally changing. Kramer explains how decades of reliance on dopamine-based antipsychotics shaped treatment, and why new mechanisms like muscarinic agonism are opening the door to safer, more effective options for patients with schizophrenia.
Get Power to the Patients summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Podcasts in similar categories.
Hidden Brain
Explores human behavior and the unconscious patterns that shape our decisions, relationships, and society through science and storytelling.
Inside AsembleAI: DeepTech, AI & Science
Experts discuss AI's impact on business, product development, and leadership with researchers, founders, and executives.
Huberman Lab
Explores neuroscience and science-based tools for understanding and improving brain function, behavior, and health.
The Jordan B. Peterson Podcast
Explores how values, religion, and culture shape individuals and society through interviews and lectures.
Gastropod
Explores the science and history behind food and farming, from ancient feasts to modern aquaculture and everything in between.
The Rest Is Science
Hannah Fry and Michael Stevens explore puzzling scientific questions that challenge everyday assumptions about reality.
Plagues with Dr. Keith
A physician examines the science, history, and societal impact of major diseases and pandemics.
Super Data Science: ML & AI Podcast with Jon Krohn
Conversations with data science experts exploring machine learning, AI, and real-world applications to advance technical skills and careers.
About Power to the Patients
Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials. We explore the bottlenecks in today's systems, challenge the status quo and talk about future opportunities for innovation.Looking for a clinical trial? Visit us at www.withpower.com
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Power to the Patients in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Power to the Patients daily summary?
It's a free AI-powered email that summarizes new episodes of Power to the Patients as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Power to the Patients podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Power to the Patients product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Brandon Li.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
What topics does Power to the Patients cover?
Power to the Patients covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Power to the Patients summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.